Sona Nanotech Inc. (SONA.CN)
| Previous Close | 0.1650 |
| Open | 0.0000 |
| Bid | 0.1650 x 0 |
| Ask | 0.1850 x 0 |
| Day's Range | 0.0000 - 0.0000 |
| 52 Week Range | |
| Volume | |
| Avg. Volume | 82,734 |
| Market Cap | 13.198M |
| Beta (5Y Monthly) | -1.95 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Newsfile
Sona Nanotech Receives Waiver on Requirement to Raise Additional Equity Capital
This news release constitutes a "designated news release" for the purposes of the Company's prospectus supplement dated April 9, 2021 to its short form base prospectus dated March 31, 2021. Halifax, Nova Scotia--(Newsfile Corp. - March 6, 2023) - Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the "Company" or "Sona") announces that Siva Therapeutics, Inc. ("Siva") and its shareholders have waived the requirement for any further equity raise by Sona prior to the closing of ...
- Newsfile
Sona Nanotech Closes Non-Brokered Private Placement Financing to Raise $1.1M in Gross Proceeds
This news release constitutes a "designated news release" for the purposes of the Company's prospectus supplement dated April 9, 2021 to its short form base prospectus dated March 31, 2021. Halifax, Nova Scotia--(Newsfile Corp. - February 24, 2023) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") is pleased to announce that it has closed its non-brokered private placement that was announced on January 26, 2023 and subsequently upsized as announced on ...
- Newsfile
Sona Nanotech to Increase Size of Equity Financing
This news release constitutes a "designated news release" for the purposes of the Company's prospectus supplement dated April 9, 2021 to its short form base prospectus dated March 31, 2021. Halifax, Nova Scotia--(Newsfile Corp. - February 21, 2023) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona") further to the Company's announcement dated January 26, 2023 that it had entered into a binding agreement (the "Definitive Agreement") to acquire Siva Therapeutics, Inc. ...
